BDX NYSE Week ended 18 Sep 2026

Weekly Investor Report

Becton Dickinson and Company · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 180.94 USD
1.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.7% above the Trend Line and sits at 83.5% of its 52-week range. The latest completed week returned 1.7%, after a -5.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bullish with 45/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: earnings are due in 44d.

Setup score 54 out of 100
Latest Close 180.94 USD 18 Sep 2026
1W Return 1.7% latest completed week
4W Return -5.2% short-term follow-through
12W Return 16.0% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 35.09% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.7% Latest completed week; four-week move -5.2%. Indicator stack 49/66 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 35.09% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 45/100 conviction; expected move 5.5%. News sentiment 53/100 26 relevant articles in the latest sentiment read. Event risk 44d Next report is scheduled for 05 Nov 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.7% above the Trend Line and sits at 83.5% of its 52-week range. The latest completed week returned 1.7%, after a -5.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug 4 Sep 11 Sep 18 Sep
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7412-week average 0.39

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.74Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -5.2% over four weeks, 16.0% over 12 weeks, and 25.4% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W1.7%
4W-5.2%
12W16.0%
26W18.2%
52W25.4%
Active trend streak5 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.93Latest activity-pressure read.
Pressure change-7.3%Four-week change in activity pressure.
Leadership6.27Latest relative-leadership reading.
RS change-49.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 18 Sep 2026 Financial statements through 30 Jun 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength45/100Blend of value, momentum, and quality. Underlying universe rank 56; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality72/100Profitability and accounting quality. Underlying universe rank 29; rank 1 is best.
Momentum73/100Medium-term price momentum. Underlying universe rank 28; rank 1 is best.
Growth2/100Revenue and earnings growth. Underlying universe rank 99; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework23/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
52.4x
Price divided by trailing earnings.
Price / sales
2.4x
Market value relative to trailing revenue.
EV / EBITDA
11.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
46.1%
Gross profit retained from each unit of revenue.
Operating margin
9.8%
Operating profit retained from revenue.
Free-cash-flow margin
12.5%
Free cash flow generated from revenue.
Return on invested capital
4.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-2.6%
Latest one-year revenue growth.
EPS growth
-40.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
2.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.2%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
2.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

BDX shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.24, expected move of 5.5%, and Sharemaestro trend signal active.

Conviction45/100
Expected move5.5%
Put/call volume0.24
Pressure67
Speculation25
Volatility43
Trend agreement29
Open options detail
Insider activity5 / 15

5 acquisitions and 15 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 26 relevant articles.

11 positive · 15 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings44dNext report is scheduled for 05 Nov 2026; event risk rises as the date approaches.
Options expected move5.5%Nearest-chain priced movement where available.
52-week drawdown-5.7%Distance below the 52-week high.
13-week volatility3.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+8.3%Week of 26 Jun.
Worst week-4.0%Week of 24 Apr.
Latest week+1.7%Week of 18 Sep.

Shape of recent returns

Strong gains5
Modest gains8
Flat weeks1
Modest losses11
Sharp losses1
Recent vol3.8%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape53/100

Trend, activity pressure, participation, and risk combine to a 53/100 tape read.

 Indicator analysis57/100

Latest 12-week confirmation: trend 5/12, activity pressure 10/12, relative leadership 7/12.

Activity pressure 0.74; 2 reversal markers Next-Week ExpectancyNegative 35.09%

Next-week expectancy is negative with a 35.09% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors52/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 71 SVQF23/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 821.0 of 1061 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options52/100

BDX shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.24, expected move of 5.5%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 5.5% Sentiment53/100

Weighted news tone is neutral across 26 relevant articles.

Becton, Dickinson Names Arthur Hu Chief Information, Digital Officer Insiders5 / 15

5 acquisitions and 15 disposals in the latest 180-day insider tape.

 Earnings44d

Next report is scheduled for 05 Nov 2026; event risk rises as the date approaches.

 Research flow3 items

2 recent research articles and 1 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
18 Sep 2026180.94 USD1.7%160.58 USD165.12 USD0.936.2713.7MOn
11 Sep 2026177.85 USD-3.2%160.64 USD165.23 USD0.944.536.6MOn
4 Sep 2026183.67 USD-2.5%160.50 USD165.34 USD1.047.238.0MOn
28 Aug 2026188.42 USD-1.3%159.81 USD165.44 USD1.0610.207.0MOn
21 Aug 2026190.89 USD4.7%158.79 USD165.55 USD1.0012.309.6MOn
14 Aug 2026182.34 USD3.7%157.65 USD165.66 USD0.765.898.0MOff
7 Aug 2026175.83 USD6.2%156.92 USD165.79 USD0.602.2611.5MOff
31 Jul 2026165.62 USD5.9%156.31 USD166.01 USD0.31-0.3710.2MOff
24 Jul 2026156.36 USD-1.1%155.83 USD166.23 USD0.16-4.896.9MOff
17 Jul 2026158.17 USD4.1%155.69 USD166.56 USD0.30-4.479.1MOff
10 Jul 2026151.94 USD-3.9%155.48 USD166.81 USD-0.07-9.728.4MOff
3 Jul 2026158.08 USD1.4%155.61 USD167.06 USD-0.37-4.938.7MOff
26 Jun 2026155.92 USD8.3%155.33 USD167.27 USD-0.69-4.2523.6MOff
19 Jun 2026143.98 USD-1.5%155.12 USD167.53 USD-1.14-13.7012.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context